- ►annals.org N Singh, VL Yu, L Mieles, MM Wagener, RC … - Annals of internal medicine, 1994 - Am Coll Physicians Intervention: Patients were stratified by their CMV antibody status and the CMV
antibody status of the donor and were randomly assigned to one of two treatment
groups. Surveillance cultures for CMV (buffy coat and urine) were done ... Cited by 134 - Related articles - All 4 versions
M Martin, R Mañez, P Linden, D Estores, J … - Transplantation, 1994 - journals.lww.com 780 TRANSPLANTATION Vol. 58, No. 7 prevention of CMV disease in a population of
adult patients undergoing liver transplantation. MATERIALS AND METHODS
Randomization and study protocol. This prospective randomized trial was ... Cited by 78 - Related articles - BL Direct - All 3 versions
DJ Winston, D Wirin, A Shaked, RW Busuttil - The Lancet, 1995 - Elsevier At the time of transplant, patients were randomised to receive either
ganciclovir (6 mg/kg body weight per day intravenously from postoperative day 1
to day 30, then 6 mg/kg per day Monday through Friday until day 100) or ... Cited by 179 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] PL Hibberd, NE Tolkoff-Rubin, D Conti, F … - Annals of internal medicine, 1995 - Am Coll Physicians • Objective: To determine why Required Request pol- icies, which mandate that
hospitals request donation from donor-eligible families, have not resulted in
in- creased organ procurement. • Setting: Stratified sample of 23 ... Cited by 166 - Related articles - BL Direct - All 5 versions
E Gane, F Saliba, GJC Valdecasas, J O' … - The Lancet, 1997 - Elsevier The Kaplan-Meier estimate of the 6-month incidence of CMV disease was 29
(18·9%) of 154 in the placebo group, compared with seven (4·8%) of 150 in the
ganciclovir group (p<0·001). In the high-risk group of seronegative ... Cited by 292 - Related articles - BL Direct - All 8 versions
AD Badley, EC Seaberg, MK Porayko, RH … - Transplantation, 1997 - journals.lww.com Badley, Andrew D.; Seaberg, Eric C.; Porayko, Michael K.; Wiesner, Russell H.;
Keating, Michael R.; Wilhelm, Mark P.; Walker, Randall C.; Patel, Robin;
Marshall, William F.; DeBernardi, Michael; Zetterman, Rowen; Steers, ... Cited by 66 - Related articles - BL Direct - All 4 versions
SS Kanj, AI Sharara, PA Clavien, JD Hamilton - Clinical Infectious Diseases, 1996 - jstor.org Cytomegalovirus (CMV) remains a major cause of problems following solid organ
transplantation, accounting for a significant increase in morbidity and
affiliated costs. Infection with CMV following orthotopic liver ... Cited by 107 - Related articles - BL Direct - All 3 versions
- ►annals.org DR Snydman, BG Werner, NN Dougherty, J … - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To study the effect of cytomegalovirus immune globulin (CMVIG) ... Cited by 137 - Related articles - BL Direct - All 3 versions
N Singh, DL Paterson, T Gayowski, MM … - Transplantation, 2000 - journals.lww.com Transplantation. Wolters Kluwer Health Logo. All Issues. ... Cited by 69 - Related articles - BL Direct - All 3 versions
RJ Stratta, MS Shaefer, RS Markin, RP Wood … - Archives of Surgery, 1989 - archsurg.highwire.org Robert J. Stratta, MD; Mark S. Shaefer, PharmD; Rodney S. Markin, MD, PhD; R.
Patrick Wood, MD; Erin M. Kennedy, MD; ... Alan N. Langnas, DO; Elizabeth C.
Reed, MD; Gail L. Woods, MD; Jeremiah P. Donovan, MD; Todd J. Pillen, PA; Cited by 102 - Related articles - All 3 versions
